Cost-effectiveness analysis of COPD screening programs in primary care for high-risk patients in China
Abstract We built a decision-analytic model to compare the cost-effectiveness of using portable spirometer and questionnaire to screen chronic obstructive pulmonary diseases (COPD) with no screening (i.e. usual care) among chronic bronchitis patient in China. A lifetime horizon and a payer perspecti...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d66cc3a31b824327a14d26d81d7ffa8f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:d66cc3a31b824327a14d26d81d7ffa8f |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:d66cc3a31b824327a14d26d81d7ffa8f2021-12-02T14:59:05ZCost-effectiveness analysis of COPD screening programs in primary care for high-risk patients in China10.1038/s41533-021-00233-z2055-1010https://doaj.org/article/d66cc3a31b824327a14d26d81d7ffa8f2021-05-01T00:00:00Zhttps://doi.org/10.1038/s41533-021-00233-zhttps://doaj.org/toc/2055-1010Abstract We built a decision-analytic model to compare the cost-effectiveness of using portable spirometer and questionnaire to screen chronic obstructive pulmonary diseases (COPD) with no screening (i.e. usual care) among chronic bronchitis patient in China. A lifetime horizon and a payer perspective were adopted. Cost data of health services including spirometry screening and treatment costs covered both maintenance and exacerbation. The result indicated that portable spirometer screening was cost-saving compared with questionnaire screening and no screening, with an incremental cost-effectiveness ratio (ICER) of −5026 and −1766 per QALY, respectively. Sensitivity analyses confirmed the robustness of the results. In summary, portable spirometer screening is likely the optimal option for COPD screening among chronic bronchitis patients China.Shuli QuXuedan YouTianyi LiuLijiao WangZheng YinYanjun LiuChong YeTing YangMao HuangHongchao LiLiwen FangJinping ZhengNature PortfolioarticleDiseases of the respiratory systemRC705-779ENnpj Primary Care Respiratory Medicine, Vol 31, Iss 1, Pp 1-9 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Diseases of the respiratory system RC705-779 |
spellingShingle |
Diseases of the respiratory system RC705-779 Shuli Qu Xuedan You Tianyi Liu Lijiao Wang Zheng Yin Yanjun Liu Chong Ye Ting Yang Mao Huang Hongchao Li Liwen Fang Jinping Zheng Cost-effectiveness analysis of COPD screening programs in primary care for high-risk patients in China |
description |
Abstract We built a decision-analytic model to compare the cost-effectiveness of using portable spirometer and questionnaire to screen chronic obstructive pulmonary diseases (COPD) with no screening (i.e. usual care) among chronic bronchitis patient in China. A lifetime horizon and a payer perspective were adopted. Cost data of health services including spirometry screening and treatment costs covered both maintenance and exacerbation. The result indicated that portable spirometer screening was cost-saving compared with questionnaire screening and no screening, with an incremental cost-effectiveness ratio (ICER) of −5026 and −1766 per QALY, respectively. Sensitivity analyses confirmed the robustness of the results. In summary, portable spirometer screening is likely the optimal option for COPD screening among chronic bronchitis patients China. |
format |
article |
author |
Shuli Qu Xuedan You Tianyi Liu Lijiao Wang Zheng Yin Yanjun Liu Chong Ye Ting Yang Mao Huang Hongchao Li Liwen Fang Jinping Zheng |
author_facet |
Shuli Qu Xuedan You Tianyi Liu Lijiao Wang Zheng Yin Yanjun Liu Chong Ye Ting Yang Mao Huang Hongchao Li Liwen Fang Jinping Zheng |
author_sort |
Shuli Qu |
title |
Cost-effectiveness analysis of COPD screening programs in primary care for high-risk patients in China |
title_short |
Cost-effectiveness analysis of COPD screening programs in primary care for high-risk patients in China |
title_full |
Cost-effectiveness analysis of COPD screening programs in primary care for high-risk patients in China |
title_fullStr |
Cost-effectiveness analysis of COPD screening programs in primary care for high-risk patients in China |
title_full_unstemmed |
Cost-effectiveness analysis of COPD screening programs in primary care for high-risk patients in China |
title_sort |
cost-effectiveness analysis of copd screening programs in primary care for high-risk patients in china |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/d66cc3a31b824327a14d26d81d7ffa8f |
work_keys_str_mv |
AT shuliqu costeffectivenessanalysisofcopdscreeningprogramsinprimarycareforhighriskpatientsinchina AT xuedanyou costeffectivenessanalysisofcopdscreeningprogramsinprimarycareforhighriskpatientsinchina AT tianyiliu costeffectivenessanalysisofcopdscreeningprogramsinprimarycareforhighriskpatientsinchina AT lijiaowang costeffectivenessanalysisofcopdscreeningprogramsinprimarycareforhighriskpatientsinchina AT zhengyin costeffectivenessanalysisofcopdscreeningprogramsinprimarycareforhighriskpatientsinchina AT yanjunliu costeffectivenessanalysisofcopdscreeningprogramsinprimarycareforhighriskpatientsinchina AT chongye costeffectivenessanalysisofcopdscreeningprogramsinprimarycareforhighriskpatientsinchina AT tingyang costeffectivenessanalysisofcopdscreeningprogramsinprimarycareforhighriskpatientsinchina AT maohuang costeffectivenessanalysisofcopdscreeningprogramsinprimarycareforhighriskpatientsinchina AT hongchaoli costeffectivenessanalysisofcopdscreeningprogramsinprimarycareforhighriskpatientsinchina AT liwenfang costeffectivenessanalysisofcopdscreeningprogramsinprimarycareforhighriskpatientsinchina AT jinpingzheng costeffectivenessanalysisofcopdscreeningprogramsinprimarycareforhighriskpatientsinchina |
_version_ |
1718389231653486592 |